Haninger-Vacariu, Natalja http://orcid.org/0000-0001-6323-1007
Anastopoulos, Kyra http://orcid.org/0009-0006-4073-6620
Aigner, Christof http://orcid.org/0000-0001-6940-8010
Sunder-Plassmann, Raute http://orcid.org/0000-0002-8297-118X
Gatterer, Constantin http://orcid.org/0000-0003-1029-085X
Ponleitner, Markus http://orcid.org/0000-0002-3709-1845
Sunder-Plassmann, Gere http://orcid.org/0000-0002-9253-9921
Schmidt, Alice http://orcid.org/0000-0002-5275-0044
Funding for this research was provided by:
Amicus Therapeutics
Article History
Received: 14 January 2024
Accepted: 30 March 2024
First Online: 18 April 2024
Declarations
:
: The institutional review board (IRB) at the Medical University of Vienna approved the study (unique IRB identifier: 1265/2014, Study of Pregnancy in CKD). All patients enrolled in the study gave written informed consent. Investigations were in accordance with the Declaration of Helsinki.
: Not applicable.
: GSP, CG, MP received honoraria and travel support from Amicus Therapeutics.MP has participated in meetings sponsored by, received speaker or consulting honoraria or travel funding from Amicus, Merck, Novartis and Sanofi-Genzyme.CG received honoraria and travel support from Amicus Therapeutics, Sanofi-Aventis and Takeda pharmaceuticals.